Pfizer’s Lyme Disease Vaccine Shows 70% Efficacy in Late-Stage Trial, Seeking Regulatory Approval
During an interview, Dr. Marc Siegel discussed the surge in estimated cases of Lyme disease in the United States and how Pfizer is developing a new vaccine for the illness.…